Demonstrates the efficient synthesis and cofactor regeneration in enzymatic methylation, suggesting a new platform for natural product synthesis.
S -Adenosyl- l -methionine (SAM) is an essential biological cofactor. However, its application in vitro is hindered by high cost and instability. This study addresses this limitation by developing a biomimetic SAM analogue, S -adenosyl- l -methylcysteine (SAMC), and an efficient enzymatic regeneration system. We established an ATP-independent synthesis of its precursor, S -adenosyl- l -cysteine (SAC), using S -adenosyl- l -homocysteine (SAH) hydrolase. Structural analysis and subsequent directed evolution of thiopurine methyltransferase from Aspergillus clavatus ( Acl TMT) and halide methyltransferase from Arabidopsis thaliana ( At HMT) yielded positive mutants, notably Acl TMT_R43A-T165M and At HMT_Q49A-V140M, which exhibited dramatically enhanced activity (33.1- and 27.1-fold increases in specific activity, respectively) and catalytic efficiency (35.5- and 12.8-fold higher k cat / K M, respectively) for SAC methylation using artificial donors MeOTs and CH 3 I, respectively. Crucially, we constructed a one-pot cofactor regeneration cycle coupling these engineered methyltransferases (MTs) with natural product MTs (MT-6 from Streptomyces cinnamoneus and MT-31 from Nostoc sp.). This system successfully synthesized various methylated flavonoids, quinone, and indole with high conversion rates (exceeding 80% in multiple cases) and identical regioselectivity compared to SAM-dependent reactions. Our work demonstrates that SAMC can functionally replace SAM, providing a cost-effective and efficient platform for in vitro methylation biocatalysis and expanding the toolbox for natural product diversification.
No takes yet. Share an insight, caveat, or question.
Tong et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: